Related Experiment Videos
Alternative graft materials for hemodialysis access.
Larry A Scher1, Howard E Katzman
1Division of Vascular Surgery, North Shore University Hospital, 300 Community Drive, Manhasset, NY 11030, USA.
Seminars in Vascular Surgery
|March 11, 2004
Summary
Autogenous arteriovenous fistulas are preferred for chronic hemodialysis. However, innovations in prosthetic graft materials are improving outcomes for patients needing hemodialysis access when fistulas are not feasible.
Area of Science:
- Nephrology
- Vascular Surgery
- Biomaterials Science
Background:
- Autogenous arteriovenous fistulas are the preferred hemodialysis access method according to recent guidelines.
- A significant portion of the dialysis population lacks suitable veins for primary arteriovenous fistulas.
- Advances in autogenous access techniques have increased procedure performance, but prosthetic grafts remain necessary for many.
Purpose of the Study:
- To review current and emerging graft materials for hemodialysis access.
- To discuss strategies for improving the patency and outcomes of prosthetic arteriovenous grafts.
- To highlight recent developments in both prosthetic and biologic hemodialysis access conduits.
Main Methods:
- Review of existing literature on hemodialysis access materials.
- Analysis of surgical outcomes with expanded polytetrafluoroethylene grafts.
- Evaluation of early results from alternative and modified graft materials.
Main Results:
- Surgical results with early expanded polytetrafluoroethylene grafts were suboptimal.
- Modifications to existing grafts and new materials show promising early results for improved patency.
- Ongoing research aims to enhance the efficacy of prosthetic and biologic hemodialysis access.
Conclusions:
- While autogenous arteriovenous fistulas are ideal, advancements in prosthetic graft technology are crucial for patients requiring hemodialysis access.
- Continued development of novel graft materials is essential to improve long-term patency and patient outcomes.
- The review focuses on improving results with both prosthetic and biologic hemodialysis access conduits.